E. Mancuzo, Deborah Strela, Luiz Fernando Ferreira Pereira, R. A. Corrêa
{"title":"家族性肺纤维化的层析模式与疾病进展或死亡率","authors":"E. Mancuzo, Deborah Strela, Luiz Fernando Ferreira Pereira, R. A. Corrêa","doi":"10.1183/13993003.congress-2019.pa1375","DOIUrl":null,"url":null,"abstract":"Background: Familial pulmonary fibrosis (FPF) is defined as an idiopathic diffuse parenchymal lung disease affecting two or more members of the same primary biological family. Aim: to evaluete if the pattern of fibrosis on HRCT has a significant impact on disease progression or mortality in patients with FPF. Methods: Baseline clinical, functional and radiological data of a FPF population were retrospectively collected and analysed according to the 2018 IPF guidelines High Resolution Computerized Tomography (HRCT) classification. There was considered disease progress, decline in CVF more then 10% in a year. Results: 49 patients were included, 29 male and 20 female patients (age at diagnosis 53 ± 8.5 years-old), with a predominance of former smokers (51%), belonging to 31 families. Radiological analysis demonstrated the presence of a “UIP“ pattern at HRCT was 15 (29 %) of patients, “Probable-UIP” in 10 (19.5 %), “Indeterminate-UIP” in 7(13,5%) and “CT features most consistent with non-IPF diagnosis” in 17 (33%) . The main diagnostic was idiopathic pulmonary fibrosis (IPF), 21(41%). Initial forced vital capacity (FVC) was 75,07 ± 17,01 % of predicted and Rest SpO2 was 92 ± 5.8%. After analysis, the survival time 28.3 ± 17 months. No difference was observed in the survival or progression of the disease when we compared the “UIP“ pattern and “Probable-UIP” with “Indeterminate-UIP” and “CT features most consistent with non-IPF diagnosis”(p = 0,81) Reference: 1-Bennett D et al. Respiratory Medicine. 2017: 126: 75-83.","PeriodicalId":178396,"journal":{"name":"ILD/DPLD of known origin","volume":"106 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Tomographic pattern and disease progress or mortality in familial pulmonary fibrosis\",\"authors\":\"E. Mancuzo, Deborah Strela, Luiz Fernando Ferreira Pereira, R. A. Corrêa\",\"doi\":\"10.1183/13993003.congress-2019.pa1375\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Familial pulmonary fibrosis (FPF) is defined as an idiopathic diffuse parenchymal lung disease affecting two or more members of the same primary biological family. Aim: to evaluete if the pattern of fibrosis on HRCT has a significant impact on disease progression or mortality in patients with FPF. Methods: Baseline clinical, functional and radiological data of a FPF population were retrospectively collected and analysed according to the 2018 IPF guidelines High Resolution Computerized Tomography (HRCT) classification. There was considered disease progress, decline in CVF more then 10% in a year. Results: 49 patients were included, 29 male and 20 female patients (age at diagnosis 53 ± 8.5 years-old), with a predominance of former smokers (51%), belonging to 31 families. Radiological analysis demonstrated the presence of a “UIP“ pattern at HRCT was 15 (29 %) of patients, “Probable-UIP” in 10 (19.5 %), “Indeterminate-UIP” in 7(13,5%) and “CT features most consistent with non-IPF diagnosis” in 17 (33%) . The main diagnostic was idiopathic pulmonary fibrosis (IPF), 21(41%). Initial forced vital capacity (FVC) was 75,07 ± 17,01 % of predicted and Rest SpO2 was 92 ± 5.8%. After analysis, the survival time 28.3 ± 17 months. No difference was observed in the survival or progression of the disease when we compared the “UIP“ pattern and “Probable-UIP” with “Indeterminate-UIP” and “CT features most consistent with non-IPF diagnosis”(p = 0,81) Reference: 1-Bennett D et al. Respiratory Medicine. 2017: 126: 75-83.\",\"PeriodicalId\":178396,\"journal\":{\"name\":\"ILD/DPLD of known origin\",\"volume\":\"106 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ILD/DPLD of known origin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2019.pa1375\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ILD/DPLD of known origin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2019.pa1375","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Tomographic pattern and disease progress or mortality in familial pulmonary fibrosis
Background: Familial pulmonary fibrosis (FPF) is defined as an idiopathic diffuse parenchymal lung disease affecting two or more members of the same primary biological family. Aim: to evaluete if the pattern of fibrosis on HRCT has a significant impact on disease progression or mortality in patients with FPF. Methods: Baseline clinical, functional and radiological data of a FPF population were retrospectively collected and analysed according to the 2018 IPF guidelines High Resolution Computerized Tomography (HRCT) classification. There was considered disease progress, decline in CVF more then 10% in a year. Results: 49 patients were included, 29 male and 20 female patients (age at diagnosis 53 ± 8.5 years-old), with a predominance of former smokers (51%), belonging to 31 families. Radiological analysis demonstrated the presence of a “UIP“ pattern at HRCT was 15 (29 %) of patients, “Probable-UIP” in 10 (19.5 %), “Indeterminate-UIP” in 7(13,5%) and “CT features most consistent with non-IPF diagnosis” in 17 (33%) . The main diagnostic was idiopathic pulmonary fibrosis (IPF), 21(41%). Initial forced vital capacity (FVC) was 75,07 ± 17,01 % of predicted and Rest SpO2 was 92 ± 5.8%. After analysis, the survival time 28.3 ± 17 months. No difference was observed in the survival or progression of the disease when we compared the “UIP“ pattern and “Probable-UIP” with “Indeterminate-UIP” and “CT features most consistent with non-IPF diagnosis”(p = 0,81) Reference: 1-Bennett D et al. Respiratory Medicine. 2017: 126: 75-83.